BioLineRx Market Cap

BioLineRx has a market cap or net worth of $15.87 million as of August 14, 2025. Its market cap has decreased by -74.57% in one year.

Market Cap

15.87M

Enterprise Value

1.98M

1-Year Change

-74.57%

Ranking

#5025

Market Cap Chart

Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $15.87M, a decrease of -53.05%. That is a compound annual growth rate of -4.60%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	15.87M	-32.43%
Dec 31, 2024	23.49M	-79.62%
Dec 31, 2023	115.26M	305.33%
Dec 29, 2022	28.44M	-71.41%
Dec 30, 2021	99.46M	66.19%
Dec 31, 2020	59.85M	124.34%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings